Bluebird’s tweaked sickle cell gene therapy clears early test – FierceBiotech
FierceBiotech |
Bluebird's tweaked sickle cell gene therapy clears early test
FierceBiotech Bluebird bio has posted early clinical data suggesting work to rescue its sickle cell gene therapy may pay off. The tweaked gene therapy triggered a jump in the proportion of vector-positive cells in the two patients treated so far, raising hopes … Bluebird marks progress on Lentiglobin gene therapy #ASH17: Bluebird touts early signs that its new-and-improved sickle cell gene therapy is working Gene Therapy in Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease and bb2121 in Relapsed … |
